Index of reports
> Disability (50)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fluorouracil disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 50 Next >>
Possible Fluorouracil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: male, weighing 89.2 kg (196.2 pounds)
Reactions: Abdominal Infection, Intestinal Perforation, Hepatic Infection, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2, qd
Indication: Colorectal Cancer
Start date: 2012-08-09
End date: 2012-08-11
Afinitor
Dosage: unk
Administration route: Oral
Indication: Colorectal Cancer
Start date: 2012-08-09
Other drugs received by patient: Avastin; Diclofenac; Avastin; Fentanyl; Finasteride; Compazine; Emla; Acyclovir; Oxaliplatin; Ambien; Zofran; Ibuprofen; Baclofen
Possible Fluorouracil side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 89.2 kg (196.2 pounds)
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Colorectal Cancer
Start date: 2012-08-09
Fluorouracil
Dosage: 1200 mg/m2, qd
Indication: Colorectal Cancer
Start date: 2012-08-09
End date: 2012-08-11
Other drugs received by patient: Oxaliplatin; Diclofenac; Acyclovir; Ambien; Finasteride; Avastin; Emla; Baclofen
Possible Fluorouracil side effects in female
Reported by a lawyer from France on 2012-07-27
Patient: female
Reactions: Cardiomyopathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
End date: 2004-11-05
Fluorouracil
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
End date: 2004-11-05
Epirubicin Hydrochloride
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
End date: 2004-11-05
Other drugs received by patient: Levothyroxine Sodium; Tamoxifen Citrate; Levothyroxine Sodium; Lipanthyl 160; Aromasin
Possible Fluorouracil side effects in 75 year old female
Reported by a consumer/non-health professional from Japan on 2012-07-27
Patient: 75 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: White Blood Cell Count Decreased, Renal Impairment, Stomatitis, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: 2431.8 mg/m2, day1-2
Start date: 2012-03-26
End date: 2012-03-26
Avastin
Indication: Large Intestine Carcinoma
Start date: 2012-03-26
End date: 2012-03-26
Oxaliplatin
Start date: 2012-04-09
End date: 2012-04-09
Oxaliplatin
Start date: 2012-04-27
End date: 2012-04-27
Fluorouracil
Start date: 2012-04-09
End date: 2012-04-09
Fluorouracil
Start date: 2012-04-27
End date: 2012-04-27
Avastin
Start date: 2012-04-09
End date: 2012-04-09
Leucovorin Calcium
Start date: 2012-04-09
End date: 2012-04-09
Fluorouracil
Start date: 2012-04-09
End date: 2012-04-09
Fluorouracil
Start date: 2012-04-27
End date: 2012-04-27
Avastin
Start date: 2012-04-27
End date: 2012-04-27
Leucovorin Calcium
Dosage: 206.3 mg/m2
Indication: Large Intestine Carcinoma
Start date: 2012-03-26
End date: 2012-03-26
Leucovorin Calcium
Start date: 2012-04-27
End date: 2012-04-27
Oxaliplatin
Dosage: 84.7 mg/m2
Indication: Large Intestine Carcinoma
Start date: 2012-03-26
End date: 2012-03-26
Fluorouracil
Dosage: 412.7 mg/m2
Indication: Large Intestine Carcinoma
Start date: 2012-03-26
End date: 2012-03-26
Other drugs received by patient: Granisetron; Atarax; Dexamethasone Sodium Phosphate; Fentanyl; Mucosta; Haloperidol; Famotidine; Sodium Bicarbonate; Midazolam
Possible Fluorouracil side effects in 75 year old female
Reported by a physician from Japan on 2012-07-26
Patient: 75 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Stomatitis, Sepsis, Platelet Count Decreased, Oropharyngeal Pain, Neutrophil Count Decreased
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Granisetron
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-03-26
End date: 2012-04-27
Oxaliplatin
Indication: Colon Cancer Metastatic
Start date: 2012-03-26
End date: 2012-04-27
Fluorouracil
Dexamethasone Sodium Phosphate
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-03-26
End date: 2012-04-27
Oxaliplatin
Indication: Large Intestine Carcinoma
Avastin
Dosage: 5 mg/kg
Indication: Colon Cancer Metastatic
Start date: 2012-03-26
End date: 2012-04-27
Levoleucovorin Calcium
Indication: Colon Cancer Metastatic
Start date: 2012-03-26
End date: 2012-04-27
Avastin
Indication: Large Intestine Carcinoma
Fluorouracil
Indication: Large Intestine Carcinoma
Start date: 2012-03-26
End date: 2012-04-29
Fluorouracil
Levoleucovorin Calcium
Indication: Large Intestine Carcinoma
Fluorouracil
Indication: Colon Cancer Metastatic
Start date: 2012-03-26
End date: 2012-04-27
Other drugs received by patient: Magnesium Oxide
Possible Fluorouracil side effects in 79 year old female
Reported by a physician from France on 2012-07-23
Patient: 79 year old female
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Oxaliplatin
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Avastin
Indication: Colon Cancer
Start date: 2011-09-19
Fluorouracil
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Other drugs received by patient: Amlodipine Besylate; Aspirin
Possible Fluorouracil side effects in male
Reported by a consumer/non-health professional from France on 2012-07-10
Patient: male
Reactions: Aphthous Stomatitis, Oesophagitis, Oral Candidiasis, Aplasia, Staphylococcal Sepsis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Oxaliplatin
Dosage: 167 milligram;
Indication: Rectal Cancer
Start date: 2012-01-19
End date: 2012-01-19
Fluorouracil
Dosage: 5510 milligram;
Indication: Rectal Cancer
Start date: 2012-01-19
End date: 2012-01-19
Other drugs received by patient: Amiodarone HCL; Tenormin
Possible Fluorouracil side effects in male
Reported by a consumer/non-health professional from France on 2012-07-10
Patient: male
Reactions: Endophthalmitis, Optic Neuritis, Blindness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Oxaliplatin
Dosage: 167 milligram;
Indication: Rectal Cancer
Start date: 2012-01-19
End date: 2012-01-19
Fluorouracil
Dosage: 5510 milligram;
Indication: Rectal Cancer
Start date: 2012-01-19
End date: 2012-01-19
Other drugs received by patient: Amiodarone HCL; Tenormin
Possible Fluorouracil side effects in 66 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: 66 year old male, weighing 55.0 kg (121.0 pounds)
Reactions: Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cetuximab
Dosage: 4mg: 25jun2012
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-11
End date: 2012-06-25
Leucovorin Calcium
Dosage: 12may2012-332mg 16-17jun2012-350mg
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-12
End date: 2012-06-17
Fluorouracil
Dosage: 12may2012(bolus)664mg 13may2012(over 48 h)1992mg 16-17jun2012(bolus)700mg 16-18jun2012 2100mg
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-12
End date: 2012-06-18
Oxaliplatin
Dosage: recent dose 16jun2012-148.7mg
Indication: Colorectal Cancer Metastatic
Start date: 2012-05-12
End date: 2012-06-16
Other drugs received by patient: Sodium Chloride
Possible Fluorouracil side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29
Patient: 58 year old female
Reactions: Cardiac Failure, Mitral Valve Incompetence, Systolic Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2, cyclic
Indication: Breast Cancer
Start date: 2002-02-25
End date: 2002-06-17
Fluorouracil
Dosage: 500 mg/m2, cyclic
Indication: Breast Cancer
Start date: 2002-02-25
End date: 2002-06-17
Epirubicin Hydrochloride
Dosage: 100 mg/m2, cyclic
Indication: Breast Cancer
Start date: 2002-02-25
End date: 2002-06-17
Possible Fluorouracil side effects in 69 year old male
Reported by a physician from Japan on 2012-06-27
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Fluorouracil side effects in 79 year old female
Reported by a physician from France on 2012-06-22
Patient: 79 year old female
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Avastin
Indication: Colon Cancer
Start date: 2011-09-19
Oxaliplatin
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Fluorouracil
Indication: Colon Cancer
Start date: 2011-09-19
End date: 2012-01-30
Other drugs received by patient: Amlodipine Besylate; Aspirin
Possible Fluorouracil side effects in female
Reported by a lawyer from France on 2012-06-22
Patient: female
Reactions: Cardiomyopathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
Fluorouracil
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
Epirubicin Hydrochloride
Dosage: 6 cycles
Indication: Breast Cancer
Start date: 2004-07-15
Other drugs received by patient: Levothyroxine Sodium
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-21
Patient: female
Reactions: Cardiac Failure, Mitral Valve Incompetence, Systolic Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2002-02-25
End date: 2002-06-17
Fluorouracil
Start date: 2002-02-25
End date: 2002-06-17
Epirubicin Hydrochloride
Start date: 2002-02-25
End date: 2002-06-17
Possible Fluorouracil side effects in 50 year old female
Reported by a individual with unspecified qualification from United States on 2012-06-14
Patient: 50 year old female, weighing 47.6 kg (104.8 pounds)
Reactions: LIP Swelling, Oesophageal Pain, Viral Infection, Nausea, Pain in Extremity, Anaphylactic Reaction, Urticaria, Muscular Weakness, Pyrexia, Loss of Employment, Diarrhoea, Dysphonia, Joint Swelling, Oesophageal Oedema, Influenza Like Illness
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: apply to upper arms 2x's a day
Administration route: Topical
Indication: Prophylaxis
Start date: 2009-10-04
End date: 2009-10-14
Fluorouracil
Dosage: apply to upper arms 2x's a day
Administration route: Topical
Indication: Skin Cancer
Start date: 2009-10-04
End date: 2009-10-14
Possible Fluorouracil side effects in 47 year old male
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient: 47 year old male, weighing 56.0 kg (123.2 pounds)
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Rash
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
Dosage: interrrupt on 23feb21.day 1 of cycle 1 only restat on 18apr2012
Indication: Head and Neck Cancer
Start date: 2012-02-23
End date: 2012-05-17
Cisplatin
Dosage: day 1
Indication: Head and Neck Cancer
Start date: 2012-02-23
Fluorouracil
Dosage: days 1-4
Indication: Head and Neck Cancer
Start date: 2012-02-23
Possible Fluorouracil side effects in 69 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-08
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Fluorouracil side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-24
Patient: 51 year old male
Reactions: Guillain-Barre Syndrome, Sensory Loss, Muscular Weakness, Mobility Decreased, Paraesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Calcium Folinate
Indication: Colorectal Cancer Stage III
End date: 2009-12-01
Irinotecan HCL
Indication: Colorectal Cancer Stage III
End date: 2009-12-01
Fluorouracil
Indication: Colorectal Cancer Stage III
End date: 2009-12-01
ALL Other Therapeutic Products
Indication: Colorectal Cancer Stage III
End date: 2009-09-01
Other drugs received by patient: Fluorouracil; Oxaliplatin
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20
Patient: female
Reactions: Alopecia, Onycholysis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Taxotere
Start date: 2010-03-26
End date: 2010-07-16
Femara
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2010-08-01
Doxorubicin Hydrochloride
Indication: Breast Cancer
Start date: 2011-03-11
End date: 2011-07-01
Taxotere
Indication: Breast Cancer
Start date: 2006-11-17
End date: 2007-01-05
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-08-01
End date: 2010-11-01
Avastin
Indication: Breast Cancer
Start date: 2010-03-26
End date: 2011-01-26
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-11-01
End date: 2011-01-01
Fluorouracil
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Tamoxifen Citrate
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2008-04-01
Possible Fluorouracil side effects in 43 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-17
Patient: 43 year old female
Reactions: Alopecia, Onycholysis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: unk
Start date: 2011-03-11
End date: 2011-07-01
Tamoxifen Citrate
Dosage: unk
Administration route: Oral
Start date: 2007-06-01
End date: 2008-04-01
Aromasin
Dosage: unk
Administration route: Oral
Start date: 2010-08-01
End date: 2010-11-01
Taxotere
Dosage: unk
Start date: 2006-11-17
End date: 2007-01-05
Avastin
Dosage: unk
Start date: 2010-08-01
End date: 2010-11-01
Epirubicin Hydrochloride
Dosage: 100 mg, unk
Start date: 2006-09-15
End date: 2006-10-27
Femara
Dosage: unk
Administration route: Oral
Start date: 2008-04-01
End date: 2010-08-01
Cyclophosphamide
Dosage: 500 mg, unk
Start date: 2006-09-15
End date: 2006-10-27
Avastin
Dosage: unk
Start date: 2010-11-01
End date: 2011-01-26
Fluorouracil
Dosage: 500 mg, unk
Start date: 2006-09-15
End date: 2006-10-27
Avastin
Dosage: unk
Start date: 2010-03-26
End date: 2010-07-16
Xeloda
Dosage: unk
Administration route: Oral
Start date: 2010-11-01
End date: 2011-01-01
Taxotere
Dosage: unk
Start date: 2010-03-26
End date: 2010-07-16
Possible Fluorouracil side effects in female
Reported by a consumer/non-health professional from South Africa on 2012-04-16
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Injection Site Extravasation, Alopecia, Thrombophlebitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Taxotere
Indication: Chemotherapy
Start date: 2008-08-27
End date: 2008-10-27
Fluorouracil
Indication: Chemotherapy
Start date: 2008-07-11
End date: 2008-07-31
Epirubicin
Indication: Chemotherapy
Start date: 2008-07-11
End date: 2008-07-31
Cyclophosphamide
Indication: Breast Cancer
Start date: 2008-07-11
End date: 2008-07-31
Possible Fluorouracil side effects in female
Reported by a physician from France on 2012-04-13
Patient: female
Reactions: Alopecia, Onycholysis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Fluorouracil
Indication: Product Used FOR Unknown Indication
Start date: 2006-09-15
End date: 2006-10-27
Tamoxifen Citrate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2007-06-01
End date: 2008-04-01
Femara
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-04-01
End date: 2010-08-01
Xeloda
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-11-01
End date: 2011-01-01
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Start date: 2006-09-15
End date: 2006-10-27
Doxorubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-11
End date: 2011-07-01
Aromasin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-11-01
Avastin
Start date: 2010-08-01
End date: 2010-11-01
Avastin
Start date: 2010-11-01
End date: 2011-01-26
Avastin
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-26
End date: 2010-07-01
Epirubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2006-09-15
End date: 2006-10-27
Taxotere
Dosage: 6 cycles
Indication: Product Used FOR Unknown Indication
Start date: 2006-11-17
End date: 2007-01-05
Taxotere
Dosage: 6 cycles
Start date: 2010-03-26
End date: 2010-07-16
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-12
Patient: female
Reactions: Alopecia, Onycholysis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2011-03-11
End date: 2011-07-01
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-08-01
End date: 2010-11-01
Taxotere
Start date: 2010-03-26
End date: 2010-07-16
Avastin
Indication: Breast Cancer
Start date: 2010-03-26
End date: 2011-01-26
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-11-01
End date: 2011-01-01
Taxotere
Indication: Breast Cancer
Start date: 2006-11-17
End date: 2007-01-05
Tamoxifen Citrate
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2008-04-01
Femara
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2010-08-01
Fluorouracil
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11
Patient: female
Reactions: Lymphangitis, Alopecia, Onycholysis, Breast Cancer Recurrent
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Tamoxifen Citrate
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2008-04-01
Fluorouracil
Indication: Breast Cancer
Taxotere
Indication: Breast Cancer
Start date: 2006-11-01
End date: 2007-01-01
Avastin
Indication: Breast Cancer
Start date: 2010-03-26
End date: 2011-01-26
Femara
Dosage: unk ukn, unk
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2010-04-01
Cyclophosphamide
Start date: 2006-09-15
End date: 2006-10-27
Epirubicin Hydrochloride
Indication: Breast Cancer
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-11-01
End date: 2011-01-01
Doxorubicin Hydrochloride
Indication: Breast Cancer
Start date: 2011-03-11
End date: 2011-07-01
Cyclophosphamide
Start date: 2011-07-01
Taxotere
Start date: 2010-03-26
End date: 2010-07-16
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-08-01
End date: 2010-11-01
Other drugs received by patient: Minoxidil; Doxorubicin HCL
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11
Patient: female
Reactions: Alopecia, Onycholysis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Breast Cancer
Start date: 2011-03-11
End date: 2011-07-01
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Avastin
Indication: Breast Cancer
Start date: 2010-03-26
End date: 2011-01-26
Taxotere
Start date: 2010-03-26
End date: 2010-07-16
Femara
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2010-08-01
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-08-01
End date: 2010-11-01
Taxotere
Indication: Breast Cancer
Start date: 2006-11-17
End date: 2007-01-05
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Fluorouracil
Indication: Breast Cancer
Start date: 2006-09-15
End date: 2006-10-27
Tamoxifen Citrate
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2008-04-01
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-11-01
End date: 2011-01-01
Possible Fluorouracil side effects in female
Reported by a physician from France on 2012-04-10
Patient: female
Reactions: Alopecia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Taxotere
Indication: Product Used FOR Unknown Indication
Start date: 2007-10-22
End date: 2007-12-03
Herceptin
Indication: Product Used FOR Unknown Indication
Start date: 2008-02-11
End date: 2009-01-16
Herceptin
Start date: 2010-12-01
Paclitaxel
Start date: 2011-02-08
End date: 2011-05-24
Aromasin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-01
End date: 2011-01-01
Paclitaxel
Dosage: drug: paclitaxel ebewe
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-10
End date: 2011-02-01
Fluorouracil
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Cyclophosphamide
Dosage: drug: paclitaxel hospira
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Epirubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Arimidex
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-03-01
Possible Fluorouracil side effects in female
Reported by a physician from France on 2012-03-23
Patient: female
Reactions: Alopecia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Herceptin
Indication: Product Used FOR Unknown Indication
Start date: 2008-02-11
End date: 2009-01-16
Fluorouracil
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Cyclophosphamide
Dosage: drug: paclitaxel hospira
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Epirubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2007-08-20
End date: 2007-10-01
Paclitaxel
Dosage: drug: paclitaxel ebewe
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-10
End date: 2011-02-01
Arimidex
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-03-01
Aromasin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-01
End date: 2011-01-01
Herceptin
Start date: 2010-12-01
Taxotere
Indication: Product Used FOR Unknown Indication
Start date: 2007-10-22
End date: 2007-12-03
Paclitaxel
Start date: 2011-02-08
End date: 2011-05-24
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-20
Patient: female
Reactions: Blood Iron Decreased, Alopecia, Hair Growth Abnormal, Hair Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Femara
Dosage: unk
Administration route: Oral
Start date: 2011-04-01
Epirubicin
Dosage: unk
Start date: 2010-10-14
End date: 2010-11-25
Fluorouracil
Dosage: unk
Start date: 2010-10-14
End date: 2010-11-25
Cyclophosphamide
Dosage: unk
Start date: 2010-10-14
End date: 2010-11-25
Taxotere
Dosage: unk
Start date: 2010-12-16
End date: 2011-01-27
Possible Fluorouracil side effects in female
Reported by a physician from Japan on 2012-03-02
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Large Intestine Perforation, Malaise, Tumour Lysis Syndrome, Dizziness, Headache, Pyrexia, Haemorrhoidal Haemorrhage, Infectious Peritonitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: route: intravenous drip
Start date: 2010-07-28
End date: 2010-11-09
Fluorouracil
Dosage: route: intravenous bolus
Indication: Colon Cancer Metastatic
Start date: 2010-07-28
End date: 2010-11-09
Fluorouracil
Start date: 2010-07-28
End date: 2011-11-01
Irinotecan HCL
Indication: Colon Cancer Metastatic
Start date: 2010-07-28
End date: 2010-11-09
Avastin
Indication: Colon Cancer Metastatic
Start date: 2010-10-19
End date: 2010-11-09
Other drugs received by patient: Oxycontin; Loxonin; Levoleucovorin Calcium; Rabeprazole Sodium; Atropine; Decadron; Orgotein; Aloxi; Decadron; Methycobal
Possible Fluorouracil side effects in 62 year old female
Reported by a physician from France on 2012-02-29
Patient: 62 year old female
Reactions: Alopecia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Herceptin
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-19
End date: 2009-09-21
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-27
End date: 2008-08-08
Taxotere
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-29
End date: 2008-10-10
Epirubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-27
End date: 2008-08-08
Fluorouracil
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-27
End date: 2008-08-08
Dexrazoxane Hydrochloride
Dosage: drug name reported as cardioxane
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-27
End date: 2008-08-08
Page 1 Next >>
|